Table 1 Descriptive data of PLWHA on ART at the regional hospital of Sokodé, Togo

Sex

*

°

°

0.283

 Male

90 (30.9)

73 (81.1)

78 (86.7)

74 (82.2)

74 (82.2)

 Female

201 (69.1)

139 (69.2)

172 (85.6)

144 (71.6)

154 (76.6)

Age

°

°

*

0.168

 Less than 25 years

26 (8.9)

21 (80.8)

25 (96.2)

17 (65.4]

21 (80.8)

 25-35 years

109 (37.5)

74 (67.9)

91 (83.5)

75 (68.8)

79 (72.5)

 More than 35 years

156 (53.6)

117 (75.0)

134 (85.9)

126 (80.8)

128 (82.1)

Marital status

°

°

°

0.330

 Single/widower/divorced

96 (33.0)

64 (66.7)

84 (87.5)

68 (70.8)

72 (75.0)

 Married/in couple

195 (67.0)

148 (75.9)

166 (85.1)

150 (76.9)

156 (80.0)

Education level

**

*

**

0.008

 Non schooled

81 (27.8)

61 (75.3)

73 (90.1)

59 (72.8)

67 (82.7)

 Primary school

105 (36.1)

62 (59.0)

83 (79.0)

69 (65.7)

71 (67.6)

 Secondary school

84 (28.9)

72 (85.7)

77 (91.7)

71 (84.5)

73 (86.9)

 High levelschool

21 (7.2)

17 (81.0)

17 (81.0)

19 (90.5)

17 (81.0)

Religion

0.287

 None or traditional

15 (5.2)

11 (73.3)

13 (86.7)

11 (73.3)

11 (73.3)

 Islam

149 (51.2)

103 (69.1)

126 (84.6)

108 (72.5)

112 (75.2)

 Christian

127 (43.6)

98 (77.2)

111 (87.4)

99 (78.0)

105 (82.7)

Place of residence

*

°

°

0.131

 Urban

194 (66.7)

133 (68.6)

165 (85.1)

145 (74.7)

147 (75.8)

 Rural

97 (33.3)

79 (81.4)

85 (87.6)

17 (75.3)

81 (83.5)

Alcohol consumption

**

*

°

≤0.001

 No

223 (76.6)

173 (77.6)

197 (88.3)

173 (77.6)

187 (83.9)

 Yes

68 (23.4)

39 (57.4)

53 (77.9)

45 (66.2)

41 (60.3)

Clinical WHO stage

°

°

°

0.242

 Stage I

53 (18.2)

39 (73.6)

45 (84.5)

39 (73.6)

41 (77.4)

 Stage II

132 (45.4)

95 (72.0)

113 (85.6)

101 (76.5)

109 (82.6)

 Stage III and IV

106 (36.4)

78 (73.6)

92 (86.8)

78 (73.6)

78 (73.6)

Duration of ART therapy

°

*

°

0.379

 Less than one year

33 (11.3)

28 (84.8)

32 (97.0)

26 (78.8)

28 (84.8)

 1 to3 years

126 (43.3)

94 (74.6)

113 (89.7)

95 (75.4)

101 (80.2)

 More than 3years

132 (45.4)

90 (68.2)

105 (79.5)

97 (73.5)

99 (75.0)

CD4’s count (last check-up)

*

*

°

0.022

 CD4 ≤ 350

116 (39.9)

76 (65.5)

93 (80.2)

83 (71.6)

83 (71.6)

 CD4 > 350

175 (60.1)

136 (77.7)

157 (89.7)

135 (77.1)

145 (82.9)

Therapeutic’s line

°

°

°

0.574

 1 ^st line

274 (94.2)

200 (73.0)

236 (86.1)

204 (74.5)

216 (78.8)

 2 ^nd line

12 (4.1)

9 (75.0)

11 (91.7)

9 (75.0)

9 (75.0)

 3rd line

5 (1.7)

3 (60.0)

3 (60.0)

5 (100.0)

3 (60.0)

Type of ART prescribed

°

°

°

0.310

 Triomune

3 (1.0)

3 (100.0)

3 (100.0)

3 (100.0)

3 (100.0)

 Duovir/EFV

36 (12.4)

22 (61.1)

31 (86.1)

25 (69.4)

27 (75.0)

 Duovir/NVP

243 (83.5)

181 (74.5)

210 (86.4)

182 (74.9)

192 (79.0)

 TNF/3TC/Aluvia

7 (2.4)

4 (57.1)

4 (57.1)

6 (85.7)

4 (57.1)

 ABC/DDI/Aluvia

2 (0.7)

2 (100.0)

2 (100.0)

2 (100.0)

2 (100.0)

Reported side effects

°

°

°

0.988

 No

240 (82.5)

175 (72.9)

210 (87.5)

178 (74.2)

188 (78.3)

 Yes

51 (17.5)

37 (72.5)

40 (78.4)

40 (78.4)

40 (78.4)

ART perception by patient

**

**

**

≤0.001

 Low

33 (11.3)

15 (45.5)

21 (63.6)

15 (45.5)

15 (45.5)

 Good

258 (88.7)

197 (76.4)

229 (88.8)

203 (78.7)

213 (82.6)

HIV-status disclosure to sexual partner

**

**

**

≤0.001

 No

84 (39.1)

39 (46.4)

62 (73.8)

48 (57.1)

46 (54.8)

 Yes

131 (60.9)

106 (80.9)

119 (90.8)

109 (83.2)

113 (86.3)

Knowledge of the HIV sero-status of the sexual partner

**

*

**

≤0.001

 No

85 (39.5)

43 (50.6)

65 (76.5)

49 (57.6)

51 (60.0)

 Yes

130 (60.5)

102 (78.5)

116 (89.2)

108 (83.1)

108 (83.1)

Self-report adherence to ART

 No

79 (27.1)

 Yes

212 (72.9)

Appointment’s adherence to ART

 No

41 (14.1)

 Yes

250 (85.9)

Pills count’s adherence to ART

 No

73 (25.1)

 Yes

218 (74.9)

Global adherence to ART

 No

63 (21.6)

 Yes

228 (78.4)